Ledger. Australian venture funding, tracked

Startup · $500k raised

Aspecthera

Novel eye-drop therapy for non-proliferative diabetic retinopathy

Coverage

Stories naming Aspecthera. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

14 deals

Life sciences investor MTPConnect injects $12 million into 14 drug and device startups

MTPConnect's government-backed accelerator program has awarded $12.07 million in non-dilutive grants to 14 Australian drug and device companies, which will also receive mentoring and support from partners including CSL and Roche Diagnostics.

Also SmartCompany·@AuManufacturing

Something wrong? Tell us